Get to know the 2026 Kia K4 trim levels and find out which one offers the best mix of features, performance, and value. The 2026 Kia K4 is one of the most compelling compact sedans made today, ...

The Kia K4 has just got a lot more practical with the arrival of a new ‘Sportswagon’ estate variant. The K4 is Kia’s latest combustion-powered model, replacing the old Cee’d hatchback as the Korean ...

Jan 12 (Reuters) - Brokerages began coverage of Medline (MDLN.O), opens new tab with largely bullish ratings on Monday, betting on supply chain strength and brand penetration, following the firm's ...

Medline has struck a series of new and expanded partnerships with health systems in recent months, reinforcing its position as a major supply chain player in both medical-surgical and laboratory ...

Good news, everyone: the 2026 Kia K4 Hatchback is officially joining Kia’s lineup as its most utilitarian (and fun) small-car option, and on Monday, we finally learned how much it costs. There will be ...

Medline CEO Jim Boyle (R) celebrates after ringing the opening bell at Nasdaq Marketsite headquarters on Dec. 17, 2025. Photo by Michael M. Santiago/Getty Images A blockbuster IPO from an ...

Medline completed a highly successful IPO, now trading at a $83 billion valuation, being granted a demanding 39x earnings multiple. Medline generates $25.5 billion in annual revenue, up 10% ...

All-new hatchback version joins K4 sedan Shorter in length but more spacious than K4 sedan Only available in three uplevel trims Pricing starts at $26,085 (all prices include $1,195 destination charge ...

Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer reviewed Medline, a medical supplies giant that made its market debut Wednesday. He said he'd wait for a pullback to buy the stock after shares ...

Medline shares close 41% above offer price in debut Tariffs pose a challenge for Medline SpaceX, others eye 2026 listing Dec 17 (Reuters) - Medical supply giant Medline's shares rose 41% above their ...

Medline shares surged more than 40% in their hotly anticipated New York debut on Wednesday, valuing the medical supply giant at $54 billion in the largest US initial public offering since Rivian’s ...

Forget weight-loss drugs and the latest development for their makers — the hottest healthcare stock right now makes those ubiquitous striped blankets for newborns and offers more than 300,000 other ...